Full-Time

Source Document Specialist

Confirmed live in the last 24 hours

McKesson

McKesson

Healthcare distribution and logistics services provider

No salary listed

Junior

Nashville, TN, USA

In Person

Category
Healthcare Administration & Support
Nursing & Allied Health Professionals
Medical, Clinical & Veterinary
Required Skills
Google Cloud Platform
Requirements
  • An Associate Degree; Bachelor Degree preferred
  • At least 2 years of experience working in health care organization – oncology preferred
  • Knowledge of scientific, medical, and regulatory terms
  • Knowledge of GCP and Good Manufacturing Practice (GMP)
  • Detail-oriented
  • Excellent English written and oral skills.
Responsibilities
  • Support the Study Coordinator to meet industry trial data deadlines.
  • Obtain source documentation for patients enrolled into clinical trial.
  • Assist the Study Coordinator with case report form completion if needed.
  • Assist the Study Coordinator with query resolution if needed.
  • Assist the Study Coordinator to obtain medical record including research chart.
  • Create and maintain spreadsheet for medical record and research chart accountability.
  • Maintain and archive study administrative files.
  • Work closely with Tennessee Oncology medical record departments to assure accountability of records.
  • Work closely with Iron Mountain to locate archived records.
  • Meet with project manager on a regular basis.
  • Assess adherence to Sarah Cannon SOPs, Good Clinical Practice (GCP) and ICH regulations and guidelines.
Desired Qualifications
  • Healthcare experience, Clinical trials support, or pharmaceutical industry experience preferred

McKesson Corporation operates in the healthcare sector, focusing on the distribution of medical products and pharmaceuticals. The company acts as a middleman, purchasing medical supplies from manufacturers and delivering them to healthcare providers, pharmacies, and hospitals. This ensures that essential medical products are available when and where they are needed. McKesson generates revenue by marking up the cost of the products they distribute and charging service fees for their logistics and supply chain management. Additionally, they provide technology solutions to help healthcare providers improve their operations. McKesson's goal is to enhance patient care by ensuring a reliable supply of medical goods and services through their extensive network and partnerships.

Company Size

N/A

Company Stage

IPO

Headquarters

Irving, Texas

Founded

1833

Simplify Jobs

Simplify's Take

What believers are saying

  • Rising demand for telehealth boosts McKesson's logistics capabilities.
  • Personalized medicine trends allow McKesson to leverage its advanced distribution networks.
  • Healthcare data analytics growth offers McKesson expansion opportunities in technology solutions.

What critics are saying

  • Legal challenges from unsolicited fax ads could harm McKesson's reputation.
  • Integration of Community Oncology Revitalization Enterprise Ventures may pose financial risks.
  • Facility closures and layoffs could disrupt operations and affect public perception.

What makes McKesson unique

  • McKesson's extensive distribution network ensures timely delivery of medical products globally.
  • The company offers technology solutions to optimize healthcare provider operations.
  • McKesson's strategic partnerships enhance its role in the global healthcare supply chain.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Performance Bonus

401(k) Company Match

Company News

Consumer Financial Services Law Monitor
Jun 20th, 2025
Supreme Court Rules Hobbs Act Does Not Bind District Courts to Agency Interpretations

The case stemmed from McKesson Corporation's allegedly unsolicited fax advertisements sent in violation of the Telephone Consumer Protection Act (TCPA).

Stroock & Stroock & Lavan LLP
Jun 2nd, 2025
McKesson Corporation Completes $2 Billion Notes Offering

Simpson Thacher represented McKesson Corporation in connection with a public offering of $2 billion aggregate principal amount of notes, consisting of $650 million aggregate principal amount of 4.650% Notes due 2030, $650 million aggregate principal amount of 4.950% Notes due 2032 and $700 million aggregate principal amount of 5.250% Notes due 2035. McKesson intends to use the net proceeds from the offering, together with cash on hand and/or commercial paper program borrowings, to fund its acquisition of a 70% controlling interest in Community Oncology Revitalization Enterprise Ventures, LLC, an internal business and administrative services organization established by Florida Cancer Specialists & Research Institute, LLC.

Slater Sentinel
Mar 26th, 2025
Virtu Financial LLC Makes New $570,000 Investment in McKesson Co. (NYSE:MCK)

Virtu Financial LLC makes new $570,000 Investment in McKesson Co. (NYSE:MCK).

Bizjournals
Mar 18th, 2025
Fortune 50 company puts local facility in midst of closing up for sale

The move came after McKesson informed the state last September that it intended to lay off 13 employees at the facility.

Slater Sentinel
Feb 24th, 2025
Wealthstream Advisors Inc. Invests $218,000 in McKesson Co. (NYSE:MCK)

Wealthstream Advisors Inc. invests $218,000 in McKesson Co. (NYSE:MCK).